Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients

Introduction: Gastric cancer (GC) is the third leading cause of cancer death and a major public health-care problem worldwide. At present, methods for plasma detection of cancer are limited. MicroRNAs (miRNAs) have recently been proposed as genetic regulators, which are deregulated in different type...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hugo Cuellar-Gomez, Ma Esther Ocharán-Hernández, Claudia C. Calzada-Mendoza, David A. Comoto-Santacruz
Formato: article
Lenguaje:EN
ES
Publicado: Permanyer 2021
Materias:
Acceso en línea:https://doaj.org/article/0eb9efce98b845ceac8561c35a033f9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0eb9efce98b845ceac8561c35a033f9f
record_format dspace
spelling oai:doaj.org-article:0eb9efce98b845ceac8561c35a033f9f2021-12-01T20:30:18ZSerum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients10.24875/CIRU.200009632444-054Xhttps://doaj.org/article/0eb9efce98b845ceac8561c35a033f9f2021-01-01T00:00:00Zhttps://www.cirugiaycirujanos.com/frame_esp.php?id=577https://doaj.org/toc/2444-054XIntroduction: Gastric cancer (GC) is the third leading cause of cancer death and a major public health-care problem worldwide. At present, methods for plasma detection of cancer are limited. MicroRNAs (miRNAs) have recently been proposed as genetic regulators, which are deregulated in different types of cancer. The miRNAs are stable in serum/plasma and can be detected. Circulating miRNAs in plasma have been proposed as potential diagnostic biomarkers in GC. Materials and methods: After reviewing the relevant literature, the expression levels of seven miRNAs (miR-16, miR-21, miR-25, miR-26a, miR-92, miR-218, miR-223, and miR-451) were assessed by quantitative reverse transcription polymerase chain reaction using TaqMan microRNA Assays (Applied Biosystems) in plasma samples from GC patients (n = 80) and healthy controls (n = 80). Results: Our results demonstrated that the expression levels of miR-21 and miR-25 were significantly upregulated in GC patients compared to healthy controls with a Fold Change of 11.551 and 60.129, respectively, while miR-223 showed downregulation in GC patients compared to healthy controls with a Fold Change of −247.281. The absolute value of Fold Change > 2 was consider significant, p < 0.05. Conclusions: Our results indicated that miR-21, miR-25, and miR-223 in plasma samples can be served as a potential noninvasive tool in detection of GC. Hugo Cuellar-GomezMa Esther Ocharán-HernándezClaudia C. Calzada-MendozaDavid A. Comoto-SantacruzPermanyerarticleGastric cancer. MicroRNAs. Plasma. Biomarker. Diagnosis.SurgeryRD1-811ENESCirugía y Cirujanos, Vol 89, Iss 6 (2021)
institution DOAJ
collection DOAJ
language EN
ES
topic Gastric cancer. MicroRNAs. Plasma. Biomarker. Diagnosis.
Surgery
RD1-811
spellingShingle Gastric cancer. MicroRNAs. Plasma. Biomarker. Diagnosis.
Surgery
RD1-811
Hugo Cuellar-Gomez
Ma Esther Ocharán-Hernández
Claudia C. Calzada-Mendoza
David A. Comoto-Santacruz
Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients
description Introduction: Gastric cancer (GC) is the third leading cause of cancer death and a major public health-care problem worldwide. At present, methods for plasma detection of cancer are limited. MicroRNAs (miRNAs) have recently been proposed as genetic regulators, which are deregulated in different types of cancer. The miRNAs are stable in serum/plasma and can be detected. Circulating miRNAs in plasma have been proposed as potential diagnostic biomarkers in GC. Materials and methods: After reviewing the relevant literature, the expression levels of seven miRNAs (miR-16, miR-21, miR-25, miR-26a, miR-92, miR-218, miR-223, and miR-451) were assessed by quantitative reverse transcription polymerase chain reaction using TaqMan microRNA Assays (Applied Biosystems) in plasma samples from GC patients (n = 80) and healthy controls (n = 80). Results: Our results demonstrated that the expression levels of miR-21 and miR-25 were significantly upregulated in GC patients compared to healthy controls with a Fold Change of 11.551 and 60.129, respectively, while miR-223 showed downregulation in GC patients compared to healthy controls with a Fold Change of −247.281. The absolute value of Fold Change > 2 was consider significant, p < 0.05. Conclusions: Our results indicated that miR-21, miR-25, and miR-223 in plasma samples can be served as a potential noninvasive tool in detection of GC.
format article
author Hugo Cuellar-Gomez
Ma Esther Ocharán-Hernández
Claudia C. Calzada-Mendoza
David A. Comoto-Santacruz
author_facet Hugo Cuellar-Gomez
Ma Esther Ocharán-Hernández
Claudia C. Calzada-Mendoza
David A. Comoto-Santacruz
author_sort Hugo Cuellar-Gomez
title Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients
title_short Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients
title_full Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients
title_fullStr Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients
title_full_unstemmed Serum miRNA profile as a potential tool for non-invasive gastric cancer diagnosis in Mexican patients
title_sort serum mirna profile as a potential tool for non-invasive gastric cancer diagnosis in mexican patients
publisher Permanyer
publishDate 2021
url https://doaj.org/article/0eb9efce98b845ceac8561c35a033f9f
work_keys_str_mv AT hugocuellargomez serummirnaprofileasapotentialtoolfornoninvasivegastriccancerdiagnosisinmexicanpatients
AT maestherocharanhernandez serummirnaprofileasapotentialtoolfornoninvasivegastriccancerdiagnosisinmexicanpatients
AT claudiaccalzadamendoza serummirnaprofileasapotentialtoolfornoninvasivegastriccancerdiagnosisinmexicanpatients
AT davidacomotosantacruz serummirnaprofileasapotentialtoolfornoninvasivegastriccancerdiagnosisinmexicanpatients
_version_ 1718404556870647808